Georgia can resume enforcing a ban on hormone replacement therapy for people under 18, a judge ruled Tuesday, putting her previous order blocking the ban on hold after a federal appeals court allowed Alabama to enforce a similar restriction.
Attorneys for the state had asked Judge Sarah Geraghty to vacate the preliminary injunction in light of the Alabama decision.
Geraghty did not go that far, but she also said keeping her injunction in place was not possible after last month's ruling on Alabama's law by a three-judge panel of the 11th Circuit Court of Appeals, which includes Georgia. She instead issued a stay, or hold, on her injunction in anticipation of a possible rehearing of the Alabama case before a larger panel of the court's judges.
A spokesperson for the Georgia attorney general’s office, Kara Richardson, said in a statement that the office was pleased with the ruling and “will continue fighting to protect the health and well-being of Georgia’s children.”
Attorneys for the plaintiffs in the Georgia case said they were disappointed “primarily for the families who are unable to get the care they need in Georgia or make medical decisions based on the best interest of their children” and stressed that their legal fight was not over.
The 11th Circuit panel's ruling last month said Alabama can implement a ban on the use of puberty blockers and hormones to treat transgender children. It came a day after Geraghty issued her preliminary injunction.
The Georgia law, Senate Bill 140, allows doctors to prescribe puberty-blocking medications, and it allows minors who are already receiving hormone therapy to continue. But it bans any new patients under 18 from starting hormone therapy. It also bans most gender-affirming surgeries for transgender people under 18.
It took effect July 1. Geraghty granted a preliminary injunction blocking it Aug. 20. The injunction was sought by several children, parents and a community transgender organization in a lawsuit challenging the ban.
In her August decision, Geraghty said the children who sought the injunction faced “imminent risks” from the ban, including depression, anxiety, eating disorders, self-harm and suicidal thoughts. She said those risks outweighed any harm to the state from an injunction.
The 11th Circuit judges who ruled on Alabama’s law said states have “a compelling interest in protecting children from drugs, particularly those for which there is uncertainty regarding benefits, recent surges in use, and irreversible effects.”
Doctors typically guide children toward therapy or voice coaching long before medical intervention.
At that point, puberty blockers and other hormone treatments are far more common than surgery. They have been available in the U.S. for more than a decade and are standard treatments backed by major doctors organizations, including the American Medical Association.
At least 22 states have now enacted laws restricting or banning gender-affirming medical care for transgender minors. Most of those states have been sued.
Florida has also appealed to the 11th U.S. Circuit Court of Appeals to overturn two rulings by U.S. District Judge Robert Hinkle. In one case, Hinkle said a state prohibition against Medicaid coverage for gender-affirming medications is unconstitutional. Hinkle also issued a preliminary injunction against a ban on the use of puberty blockers and hormone therapy to treat three children diagnosed with gender dysphoria.
On Friday, Hinkle refused to block parts of the Florida law that make it more difficult for transgender adults to access hormone therapy and surgeries.
